Discovery of cyanidin-3-O-galactoside as a novel CNT2 inhibitor for the treatment of hyperuricemia.
Zheng F, Ke J, Lin S, Ye W, Wu Z, Xu Y, Mai S, Chen Y, Guo Z, Hu H, Zhang S, Pang J, Zhang Q, Zhao Z.
Zheng F, et al. Among authors: ye w.
Bioorg Chem. 2024 Dec 30;154:108108. doi: 10.1016/j.bioorg.2024.108108. Online ahead of print.
Bioorg Chem. 2024.
PMID: 39753042